Publicaciones en las que colabora con SOLANYE JACQUELINE GUERRA OJEDA (14)

2024

  1. Levamisole Impairs Vascular Function by Blocking α-Adrenergic Receptors and Reducing NO Bioavailability in Rabbit Renal Artery

    Cardiovascular Toxicology

2023

  1. Improvement of Vascular Insulin Sensitivity by Ranolazine

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

2022

  1. Deleterious effects of levamisole, a cocaine adulterant, in rabbit aorta

    Vascular Pharmacology, Vol. 144

2021

  1. PPARγ as an indicator of vascular function in an experimental model of metabolic syndrome in rabbits

    Atherosclerosis, Vol. 332, pp. 16-23

2020

  1. Action of low doses of aspirin in inflammation and oxidative stress induced by aβ1-42 on astrocytes in primary culture

    International Journal of Medical Sciences, Vol. 17, Núm. 6, pp. 834-843

  2. Relaxant and antiadrenergic effects of ranolazine in human saphenous vein

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 58, Núm. 2, pp. 277-285

2019

  1. Changes in chemokines and chemokine receptors expression in a mouse model of alzheimer’s disease

    International Journal of Biological Sciences, Vol. 15, Núm. 2, pp. 453-463

2018

  1. Chronic exercise impairs nitric oxide pathway in rabbit carotid and femoral arteries

    Journal of Physiology, Vol. 596, Núm. 18, pp. 4361-4374

  2. Nanoparticles in medicine: A focus on vascular oxidative stress

    Oxidative Medicine and Cellular Longevity, Vol. 2018

2017

  1. Effects of photodynamic therapy in periodontal treatment: A randomized, controlled clinical trial

    Journal of Clinical Periodontology, Vol. 44, Núm. 9, pp. 915-925

  2. Neuronal effects of sugammadex in combination with rocuronium or vecuronium

    International Journal of Medical Sciences, Vol. 14, Núm. 3, pp. 224-230

2016

  1. Effects of ranolazine on astrocytes and neurons in primary culture

    PLoS ONE, Vol. 11, Núm. 3

2015

  1. Astrocytes protect neurons from Aβ1-42 peptide-induced neurotoxicity increasing TFAM and PGC-1 and decreasing PPAR-γ and SIRT-1

    International Journal of Medical Sciences, Vol. 12, Núm. 1, pp. 48-56

  2. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture

    PLoS ONE, Vol. 10, Núm. 4